Q2036 Insurance Policy Changes

HCPCS Q2036 is officially defined as "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)." HCPCS Q2036 is referenced in 2 tracked payer policy changes from Michigan Medicaid - MDHHS and Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS Q2036 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.